Both in Pharmaceuticals
Emergent Biosolutions vs Vogenx
Over the past year EBS returned −5.3% and VOGX returned −39.7%; their daily moves had a correlation of 0.14.
EBS −5.3% VOGX −39.7%Growth of $1, one year, split-adjusted
| Metric | EBS | VOGX |
|---|---|---|
| Price | $5.90 | $19.73 |
| Market cap | $302.5M | $293.1M |
| Today | −5.60% | −3.90% |
| 1 month | −15.1% | +20.4% |
| 6 months | −35.2% | — |
| Year to date | −52.3% | — |
| 1 year | −43.8% | — |
| Revenue growth (YoY) | −52.4% | — |
| Gross margin | 26.5% | — |
| Net margin | −29.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.5× | — |
| Net cash | -$332.0M | — |
| Dividend yield | — | — |
| Volatility (60d) | 64.9% | — |
| Short % of float | 19.3% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).